Market Overview

I think you’ll love what you hear,
what you’ll see and the opportunities
that will be set before you.
- Jon Najarian

McKesson Corporation Fiscal 2019 Third Quarter Conference Call Scheduled for January 31, 2019


McKesson Corporation (NYSE:MCK) will release financial results for its
third fiscal quarter ended December 31, 2018 on Thursday, January 31,
2019, following the market close at approximately 4:00 PM Eastern Time
(1:00 PM Pacific Time). The company has scheduled a conference call for
5:00 PM Eastern Time (2:00 PM Pacific Time), during which John
Hammergren, chairman and chief executive officer, Brian Tyler, president
and chief operating officer, and Britt Vitalone, executive vice
president and chief financial officer, will review these results.

The dial-in number for individuals wishing to participate on the call is
323-794-2588. Craig Mercer, senior vice president, Investor Relations is
the leader of the call and the password is ‘McKesson'. The conference
call will also be available live and archived on the company's Investor
Relations website at

About McKesson Corporation
McKesson Corporation, currently
ranked 6th on the FORTUNE 500, is a global leader in
healthcare supply chain management solutions, retail pharmacy, community
oncology and specialty care, and healthcare information technology.
McKesson partners with pharmaceutical manufacturers, providers,
pharmacies, governments and other organizations in healthcare to help
provide the right medicines, medical products and healthcare services to
the right patients at the right time, safely and cost-effectively.
United by our ICARE shared principles, our employees work every day to
innovate and deliver opportunities that make our customers and partners
more successful — all for the better health of patients. McKesson has
been named the "Most
Admired Company
" in the healthcare wholesaler category by FORTUNE, a
Place to Work
" by the Human Rights Campaign Foundation, and a top military-friendly
 by Military Friendly. For more information, visit

View Comments and Join the Discussion!